Total Raised

$617.8M

Investors Count

15

Deal Terms

1

Funding, Valuation & Revenue

7 Fundings

Tyme has raised $617.8M over 7 rounds.

Tyme's latest funding round was a Series D for $250M on December 16, 2024.

Tyme's latest post-money valuation is from December 2024.

Sign up for a free demo to see Tyme's valuations in December 2024 and more.

Tyme's 2024 revenue was $215M. Tyme's most recent revenue is from 2023.

Sign up for a free demo to see revenue data from 2023 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/16/2024

Series D

$250M

$XXM

$X.XXB

((X.XXx))

FY XXXX

5

1/17/2024

Series C

$XXM

$XXM

$215M

FY 2024

10

5/23/2023

Series B - III

$XXM

$XXM

$X.XXB

((X.XXx))

FY XXXX

10

12/7/2021

Series B - II

$XXM

$XXM

0

FY undefined

10

2/23/2021

Series B

$XXM

$XXM

0

FY undefined

10

Date

12/16/2024

1/17/2024

5/23/2023

12/7/2021

2/23/2021

Round

Series D

Series C

Series B - III

Series B - II

Series B

Amount

$250M

$XXM

$XXM

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

$X.XXB

((X.XXx))

FY XXXX

$215M

FY 2024

$X.XXB

((X.XXx))

FY XXXX

0

FY undefined

0

FY undefined

Sources

5

10

10

10

10

Start free trial
New call-to-action

Tyme Deal Terms

1 Deal Term

Tyme's deal structure is available for 1 funding round, including their Series D from December 16, 2024.

Round

Series D

Funding Date

$XXM

Pre-Money Valuation

$XXM

Post-Money Valuation

$XXM

Amount Raised

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

Board Voting

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series D

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Tyme Investors

15 Investors

Tyme has 15 investors. JG Summit invested in Tyme's Series D funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

2/23/2021

12/16/2024

2
Series B, Series D (2024)

Holding Company

Philippines

5/23/2023

12/16/2024

2
Series B - III, Series D (2024)

Venture Capital

Switzerland

12/7/2021

12/16/2024

2
Series B - II, Series D (2024)

Corporation

China

00/00/0000

00/00/0000

British International Investment

Subscribe to see more

Public-Private Partnership

United Kingdom

00/00/0000

00/00/0000

Norrsken22

Subscribe to see more

Venture Capital

South Africa

First funding

2/23/2021

5/23/2023

12/7/2021

00/00/0000

00/00/0000

Last Funding

12/16/2024

12/16/2024

12/16/2024

00/00/0000

00/00/0000

Investor

British International Investment

Norrsken22

Rounds

2
Series B, Series D (2024)
2
Series B - III, Series D (2024)
2
Series B - II, Series D (2024)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Holding Company

Venture Capital

Corporation

Public-Private Partnership

Venture Capital

Location

Philippines

Switzerland

China

United Kingdom

South Africa

Tyme Acquisitions

1 Acquisition

Tyme acquired 1 company. Their latest acquisition was Savii on May 07, 2024.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

5/7/2024

Other

$XXM

$25M

Acquired

2

Date

5/7/2024

Investment Stage

Other

Companies

Valuation

$XXM

Total Funding

$25M

Note

Acquired

Sources

2

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.